Author:
DePriest Anne Z.,Heltsley Rebecca,Black David L.,Mitchell John M.,LoDico Charles,Flegel Ronald,Cone Edward J.
Publisher
Oxford University Press (OUP)
Subject
Chemical Health and Safety,Health, Toxicology and Mutagenesis,Toxicology,Environmental Chemistry,Analytical Chemistry
Reference55 articles.
1. A review of abuse-deterrent opioids for chronic nonmalignant pain;Moorman-Li;P T,2012
2. Changes in Prevalence of Prescription Opioid Abuse after Introduction of an Abuse-Deterrent Opioid Formulation
3. Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release;Benedek;Drug Design, Development and Therapy,2011
4. Food and Drug Administration. (2013) FDA Statement: Original Opana ER relisting documentation. http://www.fda.gov/Drugs/DrugSafety/ucm351357.htm (accessed May 19, 2015).
5. Painful decision-making at FDA
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献